CervicalMethDx: A Precision DNA Methylation Test to Identify Risk of High-Grade Intraepithelial Lesions in Cervical Cancer Screening Algorithms

The CervicalMethDx test integrates DNA methylation analysis and machine learning to improve early detection of high-grade cervical lesions (high-grade squamous intraepithelial lesions), offering a noninvasive, cost-effective screening tool. Enhanced risk stratification and overtreatment reduction expand equitable access to precision prevention programs. Further validation will clarify CervicalMethDx's alignment with global cervical cancer prevention strategies.

Authors

Institutions

Publication Details

Journal
Cancer Prevention Research
Published
2025-05-29
DOI
https://doi.org/10.1158/1940-6207.capr-25-0029
Citations
1
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
1.35

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CervicalMethDx: A Precision DNA Methylation Test to Identify Risk of High-Grade Intraepithelial Lesions in Cervical Cancer Screening Algorithms

Josefina Romaguera, Ashley Ramos-Lopez, Bruce J. Trock, Teresa Díaz-Montes et al.
1 citations
Cancer Prevention Research
Cervical Cancer and HPV Research
1.35
article

CervicalMethDx: A Precision DNA Methylation Test to Identify Risk of High-Grade Intraepithelial Lesions in Cervical Cancer Screening Algorithms

Josefina Romaguera, Ashley Ramos-Lopez, Bruce J. Trock, Teresa Díaz-Montes, Fernando T. Zamunér, Laura Palmieri, Amanda García-Negrón, Keerthana Gosala, Eli Winkler, Rafael Guerrero‐Preston, Dieila Giomo de Lima, Ana Purcell‐Wiltz, Mariana Brait, David Sidransky, Yash Prashar
article en
1 citations

Abstract

The CervicalMethDx test integrates DNA methylation analysis and machine learning to improve early detection of high-grade cervical lesions (high-grade squamous intraepithelial lesions), offering a noninvasive, cost-effective screening tool. Enhanced risk stratification and overtreatment reduction expand equitable access to precision prevention programs. Further validation will clarify CervicalMethDx's alignment with global cervical cancer prevention strategies.

Cancer Prevention ResearchVol. 18(9)
MetLife (United States) (US), Mercy Medical Center (US), Johns Hopkins University (US), University of Puerto Rico System (PR), BirdLife International (KE), Johns Hopkins Medicine (US), Hospital Israelita Albert Einstein (BR), Brazilian Biosciences National Laboratory (BR), Mercy Medical Center (US)
Johns Hopkins University, Ascentage Pharma, Puerto Rico Science, Technology and Research Trust, National Institutes of Health, National Cancer Institute, National Institute on Minority Health and Health Disparities
Reduced inequalities
Openalex Percentile: Top 19%
Cervical Cancer and HPV Research
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.